Xethanol Corp - Prospectus filed pursuant to Rule 424(b)(3) (424B3)
March 25 2008 - 11:14AM
Edgar (US Regulatory)
Filed
Pursuant to Rule 424(b)(3)
File
Number 333-135121
Prospectus
Supplement No. 11
to
Prospectus dated August 10, 2007, as supplemented by
Prospectus
Supplement No. 1 dated August 14, 2007,
Prospectus
Supplement No. 2 dated September 21, 2007,
Prospectus
Supplement No. 3 dated October 10, 2007,
Prospectus
Supplement No. 4 dated November 14, 2007,
Prospectus
Supplement No. 5 dated December 3, 2007,
Prospectus
Supplement No. 6 dated December 19, 2007,
Prospectus
Supplement No. 7 dated January 11, 2008,
Prospectus
Supplement No. 8 dated January 22, 2008,
Prospectus
Supplement No. 9 dated January 23, 2008 and
Prospectus
Supplement No. 10 dated January 25, 2008
XETHANOL
CORPORATION
This
Prospectus Supplement No. 11 supplements our Prospectus dated August 10,
2007,
as supplemented by Prospectus Supplement No. 1 dated August 14, 2007, Prospectus
Supplement No. 2 dated September 21, 2007, Prospectus Supplement No. 3 dated
October 10, 2007, Prospectus Supplement No. 4 dated November 14, 2007,
Prospectus Supplement No. 5 dated December 3, 2007, Prospectus Supplement
No. 6
dated December 19, 2007, Prospectus Supplement No. 7 dated January 11, 2008,
Prospectus Supplement No. 8 dated January 22, 2008, Prospectus Supplement
No. 9
dated January 23, 2008 and Prospectus Supplement No. 10 dated January 25,
2008.
The shares covered by the Prospectus have been registered to permit their
resale
to the public by the selling stockholders named in the Prospectus. We are
not
selling any shares of common stock in this offering and will not receive
any
proceeds from this offering, except on the exercise of warrants.
Our
common stock is listed on the American Stock Exchange (“AMEX”) under the symbol
“XNL.” The last sale price reported on the AMEX for our common stock on March
24, 2008 was $0.42.
This
Prospectus Supplement includes the attached Current Report on Form 8-K dated
March 12, 2008, as filed with the U.S. Securities and Exchange Commission
on
March 25, 2008.
You
should read the Prospectus and this Prospectus Supplement No. 11, together
with
Prospectus Supplement No. 1 dated August 14, 2007, Prospectus Supplement
No. 2
dated September 21, 2007, Prospectus Supplement No. 3 dated October 10, 2007,
Prospectus Supplement No. 4 dated November 14, 2007, Prospectus Supplement
No. 5
dated December 3, 2007, Prospectus Supplement No. 6 dated December 19, 2007,
Prospectus Supplement No.7 dated January 11, 2008, Prospectus Supplement
No. 8
dated January 22, 2008, Prospectus Supplement No. 9 dated January 23, 2008
and
Prospectus Supplement No. 10 dated January 25, 2008, carefully before you
invest, including the section of the Prospectus titled “Risk Factors,” which
begins on page 5 of the Prospectus.
Neither
the Securities and Exchange Commission nor any state securities commission
has
approved or disapproved of these securities or passed upon the adequacy or
accuracy of this prospectus. Any representation to the contrary is a criminal
offense.
The
date
of this Prospectus Supplement is March 25, 2008.
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): March 12, 2008
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
(State
or
Other Jurisdiction of Incorporation)
000-50154
|
|
|
|
84-1169517
|
(Commission
File Number)
|
|
|
|
(IRS
Employer Identification No.)
|
1185
Avenue of the Americas
New
York, New York
|
|
|
|
10036
|
(Address
of Principal Executive Offices)
|
|
|
|
(Zip
Code)
|
(Registrant’s
Telephone Number, Including Area Code)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General
Instruction A.2. below):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment
of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On
March
12, 2008, Mr. Thomas J. Endres informed the board of directors of Xethanol
Corporation of his decision not to renew his employment agreement, which expired
on March 6, 2008. Mr. Endres resigned as Chief Operating Officer and Executive
Vice President of Xethanol Corporation effective 30 days from the date of his
resignation letter, or April 12, 2008.
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
Xethanol
Corporation
|
|
|
|
Date:
March 25, 2008
|
By:
|
/s/ David
R.
Ames
|
|
David
R. Ames
|
|
Chief
Executive
Officer and President
|
Xethanol Corp. (AMEX:XNL)
Historical Stock Chart
From Oct 2024 to Nov 2024
Xethanol Corp. (AMEX:XNL)
Historical Stock Chart
From Nov 2023 to Nov 2024